America’s First At-Home Cervical Cancer Screening Device Approved by FDA

Roughly 4,000 women die from cervical cancer annually in the United States, according to the CDC.

The U.S. Food and Drug Administration building in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

Women’s health company Teal Health received approval from the Food and Drug Administration (FDA) for its cancer detection tool Teal Wand, “the first and only at-home vaginal sample self-collection device for cervical cancer screening in the United States,” the company said in a May 9 statement.

When a woman has cervical cancer, the cells in the cervix, which connects the vagina to the upper part of the uterus, start to grow uncontrolled. The main cause of these cancers is infections from the human papillomavirus (HPV), a virus pathogen passed between people through sexual contact. The cancer typically occurs among women aged over 30.